Company intelligence / Profile preview
Shanghai Institute of Pharmaceutical Industry
Shanghai, Shanghai, Chinaror.org ↗
- Ownership
- Public · SHAOY
- Employees
- ~28
- Development stage
- Commercial
01
Overview
Shanghai Institute of Pharmaceutical Industry has developed and commercialized multiple pharmaceutical products in China, including approved therapies for infectious and neurological diseases, supported by a broad patent portfolio[7].
- Therapeutic areas
- ImmunologyNeurologyInfectious DiseasesOncologyEndocrinology
- Modalities
- Small moleculeFusion proteinHerbal medicineLiposomal drugChemical drug
- Industry
- Pharma
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Shanghai Institute of Pharmaceutical Industry.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Institute of Pharmaceutical Industry.